ロード中...
Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: relation to disease progression
High-dose (28-30mg/kg/day) ursodeoxycholic acid (UDCA) treatment improves serum liver tests in patients with primary sclerosing cholangitis (PSC) but does not improve survival and is associated with increased rates of serious adverse events. The mechanism for the latter undesired effect remains uncl...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2928060/ https://ncbi.nlm.nih.gov/pubmed/20564380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.23631 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|